title: Vattikuti Institute Prostatectomy: a single-team experience of 100 cases.
abstract: OBJECTIVE
  To analyze the outcomes of the first 100 patients undergoing robotic radical prostatectomy by a single surgical team.
  
  
  METHODS
  From August 2001 to May 2002, we performed robotic radical prostatectomy in 100 patients with localized prostate cancer. The mean age was 60 +/- 0.67 years (SEM), the body mass index 27.5 +/- 0.35, the preoperative prostate specific antigen concentration 7.2 +/- 0.86 ng/mL, and follow-up 5.5 +/- 0.24 months. Thirty-eight patients also underwent pelvic lymph node dissection. We used the da Vinci surgical system and a subperitoneal approach (the Vattikuti Institute Prostatectomy; VIP). This is a prospective outcomes analysis of these patients.
  
  
  RESULTS
  The mean operating time was 195 +/- 5.0 minutes, and the mean blood loss was 149 +/- 11.8 mL. No patient required blood transfusion. The stages of the cancers were pT(2a) in 21, pT(2b) in 64, pT(3a) in 5, pT(3b) in 9, and pT(3b)N(1) in 1. The positive surgical margin rate was 15%. At 1, 3, and 6 months, the continence rates were 37%, 72%, and 92%, respectively, and the potency rates were 11%, 32%, and 59%.
  
  
  CONCLUSIONS
  The VIP is a safe operation with excellent operative parameters, low morbidity, and good surgical margins. The early functional results are promising.
authors.affiliation: Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan 48202, USA.
authors.forename: Mani
authors.initials: M
authors.lastname: Menon
authors.forename: Alok
authors.initials: A
authors.lastname: Shrivastava
authors.forename: Richard
authors.initials: R
authors.lastname: Sarle
authors.forename: Ashok
authors.initials: A
authors.lastname: Hemal
authors.forename: Ashutosh
authors.initials: A
authors.lastname: Tewari
mesh_terms: D000328:Adult; D000368:Aged; D006801:Humans; D008297:Male; D008824:Michigan; D008875:Middle Aged; D011446:Prospective Studies; D011468:Prostatectomy / Q000009:adverse effects; D011471:Prostatic Neoplasms / Q000473:pathology / Q000601:surgery*; D012371:Robotics